Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sen. Tim Scott (R-S.C.) has become the longest-serving Black senator in U.S. history, as the 119th Congress begins Friday. Scott was appointed to the Senate in 2012 by then-Gov. Nikki Haley (R ...

Te Waarakihi Hooper Felise needs a bone marrow transplant. Most boys Te Waarakihi Felise Hooper’s age want toys, games and lollies for their birthdays - but the Rotorua boy is likely to be happy ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Just a few weeks ago, Merck (known as MSD outside North America) paid $425 million to get hold of OncoImmune. The headline of the deal was an experimental COVID-19 drug, but it also claimed rights ...

Animals: Art, Science and Sound (21 April – 28 August 2023) at the British Library reveals how the intersection of science, art and sound has been instrumental in our understanding of the natural ...

After hours: January 3 at 7:59:30 p.m. EST ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...